Redmile Group, LLC
CIK 1425738 · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$134.25M
Companies
16
Total Filings
30
Lifetime Open-Market Net
$152.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADCT | 10%+ Owner | 25,735,799 | $1.05 | $27.02M | -$58.91M | 2 | 2026-04-02 |
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 2,964,843 | $1.27 | $3.77M | $14.63M | 4 | 2025-07-02 |
| STTK | Director | 5,539,724 | $4.94 | $27.37M | $0 | 1 | 2024-12-06 |
| Augmedix, Inc. (AUGX) Delisted | Director | 25,850,163 | $2.35 | $60.75M | $37.50M | 2 | 2023-11-22 |
| ABSI | Director | — | $6.80 | — | $0 | 1 | 2022-06-10 |
| TRDA | 10%+ Owner | 954,420 | $6.46 | $6.17M | $60.00M | 1 | 2021-11-04 |
| Science 37 Holdings, Inc. (SNCE) Delisted | Director | 19,750,786 | $5.75 | $113.57M | $0 | 1 | 2021-10-08 |
| FATE | Director | 12,957,222 | $2.06 | $26.69M | $56.00M | 1 | 2021-01-12 |
| NRIX | 10%+ Owner | 1,176,470 | $16.95 | $19.94M | $0 | 1 | 2020-07-30 |
| PLRX | 10%+ Owner | 1,910,657 | $1.13 | $2.16M | $0 | 1 | 2020-06-09 |
| CABA | 10%+ Owner | 696,378 | $3.01 | $2.10M | $0 | 1 | 2019-10-29 |
| APRE | 10%+ Owner | 1,868,718 | $0.69 | $1.28M | $12.00M | 1 | 2019-10-08 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | — | — | — | $0 | 4 | 2019-07-01 |
| HOOK | 10%+ Owner | 999,322 | $1.15 | $1.15M | $0 | 1 | 2019-04-24 |
| XERS | 10%+ Owner | 3,000,642 | $6.79 | $20.37M | $31.76M | 2 | 2019-02-21 |
| Gritstone bio, Inc. (GRTS) Delisted | 10%+ Owner | 869,562 | $0.03 | $28.0K | $0 | 1 | 2018-10-03 |
Recent Filings · Page 3 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-21 | XERS | Buy (P) | +1,176,000 | $11.76M | EDGAR |
| 2019-01-03 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Other (J) | — | $0 | EDGAR |
| 2018-10-03 | Gritstone bio, Inc. (GRTS) Delisted | Conv (C) | +2,789,058 | $0 | EDGAR |
| 2018-07-18 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Other (J) | — | $0 | EDGAR |
| 2018-06-27 | XERS | Mixed | +4,825,284 | $20.00M | EDGAR |
| 2018-05-25 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-14 | — | Buy (P) | +150,000 | $540.0K | |
| 2016-01-11 | — | Buy (P) | +1,200,280 | $5.50M | |
| 2015-08-25 | — | Buy (P) | +1,580,000 | $8.50M | |
| 2015-08-13 | — | Buy (P) | +1,065,000 | $6.26M |
Showing 21–30 of 30
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.